299 related articles for article (PubMed ID: 32881272)
1. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
Thachil J; Longstaff C; Favaloro EJ; Lippi G; Urano T; Kim PY;
J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
[No Abstract] [Full Text] [Related]
2. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
[No Abstract] [Full Text] [Related]
3. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
Betoule A; Martinet C; Gasperini G; Muller P; Foucher S; Benner P; Renard A
J Thromb Thrombolysis; 2020 Aug; 50(2):302-304. PubMed ID: 32504449
[No Abstract] [Full Text] [Related]
5. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L
J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
[TBL] [Abstract][Full Text] [Related]
6. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Pawlowski C; Wagner T; Puranik A; Murugadoss K; Loscalzo L; Venkatakrishnan AJ; Pruthi RK; Houghton DE; O'Horo JC; Morice WG; Williams AW; Gores GJ; Halamka J; Badley AD; Barnathan ES; Makimura H; Khan N; Soundararajan V
Elife; 2020 Aug; 9():. PubMed ID: 32804081
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
Wanderer JP; Nathan N
Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
[No Abstract] [Full Text] [Related]
9. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
Speed V; Patel RK; Byrne R; Roberts LN; Arya R
Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
[No Abstract] [Full Text] [Related]
10. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
11. 2020 - Year of COVID-19.
Lillicrap D; Morrissey JH
J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
[No Abstract] [Full Text] [Related]
12. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
[TBL] [Abstract][Full Text] [Related]
13. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
15. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
Cui S; Chen S; Li X; Liu S; Wang F
J Thromb Haemost; 2020 Jun; 18(6):1421-1424. PubMed ID: 32271988
[TBL] [Abstract][Full Text] [Related]
16. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and SIC (!).
Nevzorov I; Tulamo R; Albäck A; Lassila R
J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
[No Abstract] [Full Text] [Related]
18. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
Zhang L; Yan X; Fan Q; Liu H; Liu X; Liu Z; Zhang Z
J Thromb Haemost; 2020 Jun; 18(6):1324-1329. PubMed ID: 32306492
[TBL] [Abstract][Full Text] [Related]
19. D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019: a meta-analysis.
Lima WG; Barra A; Brito JCM; Nizer WSC
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):335-338. PubMed ID: 32618589
[No Abstract] [Full Text] [Related]
20. D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series.
Wang X; Du B; Li J; Wang S; Wang X; Guo M; Yang B; Si D; Bai O
Medicine (Baltimore); 2020 Jul; 99(31):e21513. PubMed ID: 32756189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
